Robert D Harrington

Summary

Affiliation: University of Washington
Country: USA

Publications

  1. pmc A species barrier limits transmission of chronic wasting disease to mink (Mustela vison)
    Robert D Harrington
    Department of Comparative Medicine, University of Washington, Seattle, WA 98195 7190, USA
    J Gen Virol 89:1086-96. 2008
  2. doi request reprint Cytokine antibody array analysis in brain and periphery of scrapie-infected Tg338 mice
    Denise M Newsom
    Department of Comparative Medicine, University of Washington, Seattle, WA 98195 7190, USA
    Comp Immunol Microbiol Infect Dis 34:387-97. 2011
  3. ncbi request reprint Optimal timing of routine vaccination in HIV-infected persons
    Heidi M Crane
    Center for AIDS and STD Research, University of Washington, Harborview Medical Center, Box 359931, 325 9th Avenue, Seattle, WA 98104, USA
    Curr HIV/AIDS Rep 6:93-9. 2009
  4. doi request reprint A controlled study of the effectiveness of public health HIV partner notification services
    Matthew R Golden
    Center for AIDS and STD, University of Washington, Seattle, WA 98104, USA
    AIDS 23:133-5. 2009
  5. pmc Independent clinical predictors of impaired response to hepatitis B vaccination in HIV-infected persons
    H Nina Kim
    Department of Medicine, Harborview Medical Center, University of Washington, Seattle, WA, USA
    Int J STD AIDS 19:600-4. 2008
  6. ncbi request reprint Hepatitis C virus activation in HIV-infected patients initiating highly active antiretroviral therapy
    H Nina Kim
    Department of Medicine, University of Washington, Seattle, Washington 98104, USA
    AIDS Patient Care STDS 21:718-23. 2007
  7. ncbi request reprint Amprenavir and didanosine are associated with declining kidney function among patients receiving tenofovir
    Heidi M Crane
    Department of Medicine, University of Washington, Seattle, Washington 98104, USA
    AIDS 21:1431-9. 2007
  8. ncbi request reprint Ongoing risk behavior among persons with HIV in medical care
    Matthew R Golden
    Public Health Seattle and King County, Seattle, USA
    AIDS Behav 11:726-35. 2007
  9. ncbi request reprint Routine collection of patient-reported outcomes in an HIV clinic setting: the first 100 patients
    Heidi M Crane
    The Department of Medicine, University of Washington, Seattle, Washington, USA
    Curr HIV Res 5:109-18. 2007
  10. ncbi request reprint Electronic human immunodeficiency virus (HIV) clinical reminder system improves adherence to practice guidelines among the University of Washington HIV Study Cohort
    Mari M Kitahata
    Department of Medicine, University of Washington, Harborview Medical Center, Box 359931, 325 9th Ave, Seattle, WA 98104, USA
    Clin Infect Dis 36:803-11. 2003

Detail Information

Publications18

  1. pmc A species barrier limits transmission of chronic wasting disease to mink (Mustela vison)
    Robert D Harrington
    Department of Comparative Medicine, University of Washington, Seattle, WA 98195 7190, USA
    J Gen Virol 89:1086-96. 2008
    ..The demonstration of a species barrier in cervid-to-mustelid prion transmission indicates that mink are unlikely to be involved in natural CWD transmission...
  2. doi request reprint Cytokine antibody array analysis in brain and periphery of scrapie-infected Tg338 mice
    Denise M Newsom
    Department of Comparative Medicine, University of Washington, Seattle, WA 98195 7190, USA
    Comp Immunol Microbiol Infect Dis 34:387-97. 2011
    ..These cytokines could suggest future targets for biomarkers of infection and may, as well, provide insight into the biologic dynamics of prion-associated neurologic diseases...
  3. ncbi request reprint Optimal timing of routine vaccination in HIV-infected persons
    Heidi M Crane
    Center for AIDS and STD Research, University of Washington, Harborview Medical Center, Box 359931, 325 9th Avenue, Seattle, WA 98104, USA
    Curr HIV/AIDS Rep 6:93-9. 2009
    ..However, risks of delaying vaccination include that the patient may be exposed to the pathogen or lost to follow-up before vaccination. We review recent studies on the timing of routine vaccination of HIV-infected individuals...
  4. doi request reprint A controlled study of the effectiveness of public health HIV partner notification services
    Matthew R Golden
    Center for AIDS and STD, University of Washington, Seattle, WA 98104, USA
    AIDS 23:133-5. 2009
    ..45%, odds ratio = 2.5, 95% confidence interval = 1.6-3.9)...
  5. pmc Independent clinical predictors of impaired response to hepatitis B vaccination in HIV-infected persons
    H Nina Kim
    Department of Medicine, Harborview Medical Center, University of Washington, Seattle, WA, USA
    Int J STD AIDS 19:600-4. 2008
    ..033), after adjusting for these other covariates. Our findings underscore the importance of confirming seroconversion after HB vaccination in HIV-infected patients and initiating vaccination early in the course of HIV infection...
  6. ncbi request reprint Hepatitis C virus activation in HIV-infected patients initiating highly active antiretroviral therapy
    H Nina Kim
    Department of Medicine, University of Washington, Seattle, Washington 98104, USA
    AIDS Patient Care STDS 21:718-23. 2007
    ..These observations suggest that flares of hepatitis C in the setting of the immune reconstitution inflammatory syndrome can occur even in those patients who have undetectable serum HCV levels prior to HAART initiation...
  7. ncbi request reprint Amprenavir and didanosine are associated with declining kidney function among patients receiving tenofovir
    Heidi M Crane
    Department of Medicine, University of Washington, Seattle, Washington 98104, USA
    AIDS 21:1431-9. 2007
    ..To examine the effect of antiretroviral agents and clinical factors on the development of tenofovir-associated kidney dysfunction...
  8. ncbi request reprint Ongoing risk behavior among persons with HIV in medical care
    Matthew R Golden
    Public Health Seattle and King County, Seattle, USA
    AIDS Behav 11:726-35. 2007
    ..These findings demonstrate the persistence of high-risk behavior among persons with HIV, a rapid increase in the use of the Internet among MSM to find sex partners, and provide direct evidence for serosorting among MSM...
  9. ncbi request reprint Routine collection of patient-reported outcomes in an HIV clinic setting: the first 100 patients
    Heidi M Crane
    The Department of Medicine, University of Washington, Seattle, Washington, USA
    Curr HIV Res 5:109-18. 2007
    ..We examined the feasibility of using a web-based application on tablet PCs with touch screens to collect PROs in a busy, multi-provider, outpatient HIV clinical care setting...
  10. ncbi request reprint Electronic human immunodeficiency virus (HIV) clinical reminder system improves adherence to practice guidelines among the University of Washington HIV Study Cohort
    Mari M Kitahata
    Department of Medicine, University of Washington, Harborview Medical Center, Box 359931, 325 9th Ave, Seattle, WA 98104, USA
    Clin Infect Dis 36:803-11. 2003
    ..86; 95% CI, 1.05-3.27; P=.03) and syphilis infection (OR, 3.71; 95% CI, 2.37-5.81; P<.0001). HIV clinical reminders delivered at the time that HIV care is provided were associated with more timely initiation of recommended practices...
  11. ncbi request reprint Pharmacy-based assessment of adherence to HAART predicts virologic and immunologic treatment response and clinical progression to AIDS and death
    Mari M Kitahata
    Department of Medicine, University of Washington, Seattle, Washington 98104, USA
    Int J STD AIDS 15:803-10. 2004
    ..2). Patients who progressed to AIDS or death had significantly higher viral loads (P = 0.01) and lower CD4 cell counts (P = 0.03) than patients who experienced virologic failure, but did not progress...
  12. ncbi request reprint Broad spectrum of dermatologic manifestations caused by Mycobacterium haemophilum infection
    William M Geisler
    Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Box 356523, HSB BB1223, 1959 NE Pacific St, Seattle, WA 98195, USA
    Arch Dermatol 138:229-30. 2002
  13. ncbi request reprint Fatal Kaposi's sarcoma-associated immune reconstitution following HAART initiation
    Heidi M Crane
    Department of Medicine, Center for AIDS and STD, Seattle, WA, USA
    Int J STD AIDS 16:80-3. 2005
    ..This case also illustrates the possibility of cryptic visceral KS with minimal cutaneous disease, as well as the potential for differential responses of cutaneous and visceral KS to treatment...
  14. ncbi request reprint HIV infection and antiretroviral therapy: effect on hepatitis C virus quasispecies variability
    Margaret C Shuhart
    Department of Medicine, University of Washington, Seattle, USA
    J Infect Dis 193:1211-8. 2006
    ..The effects of human immunodeficiency virus (HIV) coinfection and highly active antiretroviral therapy (HAART) on HCV quasispecies variability have not been firmly established...
  15. ncbi request reprint Antiretroviral therapy: a primer for dermatologists
    H Nina Kim
    Division of Allergy and Infectious Diseases, University of Washington School of Medicine, 325 Ninth Avenue, Seattle WA 98104, USA
    Dermatol Clin 24:537-47, vii. 2006
    ....
  16. pmc Generation of HIV-1-specific CD8+ cell responses following allogeneic hematopoietic cell transplantation
    Ann E Woolfrey
    Fred Hutchinson Cancer Research Center, Seattle, WA, USA
    Blood 112:3484-7. 2008
    ..We conclude that allogeneic HCT offers the unique ability to characterize de novo HIV-1-specific immune responses. This clinical trial was registered at ClinicalTrials.gov (identifier: NCT00112593)...
  17. ncbi request reprint Relapse of secondary syphilis after benzathine penicillin G: molecular analysis
    Michael Myint
    Department of Medicine Infectious Diseases, University of Washington School of Medicine, Seattle, Washington, USA
    Sex Transm Dis 31:196-9. 2004
    ..It is difficult to distinguish between relapse and reinfection in patients who develop a second episode of syphilis after treatment...
  18. doi request reprint Tenofovir-associated decline in renal function
    Heidi M Crane
    J Infect Dis 198:937; author reply 937-8. 2008